Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E-Stim Coverage Decision Reverses 1997 CMS Stance, Specifies Wound Types

This article was originally published in The Gray Sheet

Executive Summary

CMS' July 23 decision to cover electrical stimulation as an adjunctive treatment for chronic wound healing is restricted to certain types of wounds

You may also be interested in...



E-Stim Treatment For Wound Healing Receives Favorable MCAC Review

The Medicare Coverage Advisory Committee's Medical/Surgical Procedures advisory panel stopped short of designating electrostimulation as "breakthrough" technology for the treatment of chronic non-healing ulcers due to a lack of evidence suggesting that the procedure is considered a new standard of care.

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.

Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line

The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel